Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chronic Kidney Diseases
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 19 years and 84 years
- Gender
- Both males and females
Description
Prospective, open label, multicenter randomized clinical trial
Prospective, open label, multicenter randomized clinical trial
Tracking Information
- NCT #
- NCT04708587
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jung-Sun Kim, MD, PhD, FESC Severance Hospital
Get Well Soon